Drug Trial Radar · NCT03701399
Troriluzole in Adult Participants With Spinocerebellar Ataxia
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
299
Actual
Start
Mar 8, 2019
Primary completion
Feb 18, 2022
Study completion Aug 3, 2026
Sponsor
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 10, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of Troriluzole (200 mg once daily) versus placebo after 48 weeks of treatment in subjects with spinocerebellar ataxia (SCA).
Conditions
- Spinocerebellar Ataxias
- Spinocerebellar Ataxia Type 1
- Spinocerebellar Ataxia Type 2
- Spinocerebellar Ataxia Type 3
- Spinocerebellar Ataxia Type 6
- Spinocerebellar Ataxia Type 7
- Spinocerebellar Ataxia Type 8
- Spinocerebellar Ataxia Type 10
Interventions
troriluzoleDrug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Randomization Phase: Change From Baseline in the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) Total Score at Week 48 in SCA ParticipantsTime frame: Randomization Baseline; Week 48
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
CNS Trials
Long Beach, California
UCLA
Los Angeles, California
UCSF
San Francisco, California
University of Colorado Hospital
Aurora, Colorado
University of Florida Health
Gainesville, Florida
Mayo Clinic Florida
Jacksonville, Florida
University of South Florida
Tampa, Florida
Emory
Atlanta, Georgia
Northwestern University
Chicago, Illinois
University of Chicago
Chicago, Illinois
Northwest Neurology, Ltd.
Rolling Meadows, Illinois
Johns Hopkins Medicine
Lutherville, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Columbia University
New York, New York
Duke University Movement Disorders Clinic
Durham, North Carolina
University of Pennsylvania
Philadelphia, Pennsylvania
Houston Methodist
Houston, Texas
Swedish Health Services
Seattle, Washington
Central South University Xiangya Hospital
Changsha, Hunan, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.